医学
囊性纤维化
临床终点
不利影响
阿兹屈南
安慰剂
内科学
随机对照试验
吸入
外科
抗生素
麻醉
抗生素耐药性
替代医学
病理
亚胺培南
微生物学
生物
作者
Francis J Gilchrist,S. Bui,Silvia Gärtner,Susanna A. McColley,Harm A.W.M. Tiddens,Gary Ruiz,Florian Stehling,Muhsen Al-ani,Oksana Gurtovaya,Mark Bresnik,Timothy R. Watkins,Biliana Frankovic,Marianne Skov
标识
DOI:10.1016/j.jcf.2023.06.008
摘要
Antibiotic eradication therapies recommended for newly isolated Pseudomonas aeruginosa (Pa) in people with cystic fibrosis (pwCF) can be burdensome. ALPINE2 compared the efficacy and safety of a shortened 14-day course of aztreonam for inhalation solution (AZLI) with 28-day AZLI in paediatric pwCF.
科研通智能强力驱动
Strongly Powered by AbleSci AI